Form 8-K - Current report:
SEC Accession No. 0001193125-25-268102
Filing Date
2025-11-06
Accepted
2025-11-06 07:38:36
Documents
12
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sln-20251106.htm   iXBRL 8-K 57231
2 EX-99.1 sln-ex99_1.htm EX-99.1 243386
3 GRAPHIC img248120592_0.jpg GRAPHIC 15099
  Complete submission text file 0001193125-25-268102.txt   486767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20251106.xsd EX-101.SCH 56446
15 EXTRACTED XBRL INSTANCE DOCUMENT sln-20251106_htm.xml XML 6334
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 251456199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)